Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.15
Delayed Data
As of Jun 21
 -0.05 / -0.61%
Today’s Change
2.65
Today|||52-Week Range
8.60
+167.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues3.7M2.8M8.9M3.4M
 
 
 
 
 
Depreciation And Amortization248.0K252.0K252.0K301.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.3M21.8M18.5M19.9M
 
 
 
 
 
Research And Development19.5M17.0M13.9M12.9M
 
 
 
 
 
Total Operating Expenses30.5M22.0M18.8M20.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.8M-19.2M-9.8M-16.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.6M-19.0M-9.6M-16.6M
 
 
 
 
 
Income Taxes-24.0K-3.0K-13.0K0.00
 
 
 
 
Net Income-26.6M-19.0M-9.6M-16.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.5M70.6M70.7M71.0M
 
 
 
 
 
Shares To Calculate EPS Diluted70.5M70.6M70.7M71.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.27-$0.14-$0.23
 
 
 
 
 
EPS Diluted-$0.38-$0.27-$0.14-$0.23